2009
DOI: 10.1002/pbc.22214
|View full text |Cite
|
Sign up to set email alerts
|

De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system

Abstract: We present a case of a 14‐year‐old male with a germline TP53 mutation who presented with synchronous primitive neuroectodermal tumor and choroid plexus carcinoma. Identification of synchronous brain tumors prompted genetic testing for predisposition to malignancy. Within 5 months of presentation, the child developed widely metastatic alveolar rhabdomyosarcoma. Patient DNA sequencing showed a TP53 allele with a premature stop codon in the oligomerization/nuclear export signal (NES) domain (R342ter). The child's… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 12 publications
(16 reference statements)
1
6
0
Order By: Relevance
“…The former is scarce in humans and only detected on electron microscopy studies. The pigment morphology and staining features we have observed are similar to what has been described histologically and most probably corresponds to lipofuscin. This pigment is an intralysosomal, wear‐and‐tear product related to oxidative stress of proteins and lipids that accumulates with advancing age.…”
Section: Discussionsupporting
confidence: 87%
“…The former is scarce in humans and only detected on electron microscopy studies. The pigment morphology and staining features we have observed are similar to what has been described histologically and most probably corresponds to lipofuscin. This pigment is an intralysosomal, wear‐and‐tear product related to oxidative stress of proteins and lipids that accumulates with advancing age.…”
Section: Discussionsupporting
confidence: 87%
“…They account for approximately 4% of pediatric CNS tumors (Kaderali et al 2009) and are seen in about 10% of CMMRD-related brain tumors with a median age at diagnosis of 8 years (range 4-17 years) (Wimmer et al 2014). PNETs have also been reported in association with LFS (Schniederjan et al 2009;Stecher et al 2008) but at a frequency that appears to be less than CPCs. Among the limited case reports in the medical literature, the age of onset ranges from 10 to 14 years.…”
Section: Primitive Neuroectodermal Tumor (Pnet)mentioning
confidence: 99%
“…Accumulating evidence shows that CPP and CPC are strongly associated with LFS in families that carry TP53 germline mutations [1,46,20,21]. In 2008, a novel TP53 germline mutation E285V substitution was identified in a rare case of pediatric adrenocortical carcinoma and choroid plexus carcinoma [22].…”
Section: Discussionmentioning
confidence: 99%